Pharmacovigilance of hepatitis B vaccines;Pharmacovigilance des vaccins contre l'hépatite B

Bulletin de l'Academie Nationale de Medecine

Volumn 187, Issue 8, 2003, Pages 1489-1500

  Imbs, Jean Louis ^a,b   Decker, Nicole ^c   Welsch, Marie ^c   Aron, Émile ^c   Sraer, Jean Daniel ^c   Blancher, Gabriel ^c   Arthuis, Michel ^c  

^a ACADÉMIE NATIONALE DE MÉDECINE   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c NONE

Author keywords

Demyelinating diseases; Hepatitis B vaccines; Pharmacovigilance

Indexed keywords

HEPATITIS B VACCINE;

CENTRAL NERVOUS SYSTEM DISEASE; CHRONOLOGY; CLINICAL OBSERVATION; DEMYELINATING DISEASE; DISEASE ASSOCIATION; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; FRANCE; GUILLAIN BARRE SYNDROME; HUMAN; METHODOLOGY; MULTIPLE SCLEROSIS; PERIPHERAL NEUROPATHY; POPULATION RESEARCH; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; VACCINATION; VALIDATION PROCESS; ADOLESCENT; ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; CHILD; EPIDEMIOLOGY; FEMALE; HEPATITIS B; INCIDENCE; INFANT; MALE; NEWBORN;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CAUSALITY; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; DEMYELINATING DISEASES; FEMALE; FRANCE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE;

EID: 3442895007     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33885-3     Document Type: Review

References (6)

1. WELSCH M., ALT M., RICHARD M.H., IMBS J.L. - Le réseau de pharmacovigilance français : structure et missions. La Presse Médicale, 2000, 29, 102-106.
2. POSER C.M., PATY D.W., SCHEINBERG L., MCDONALD W.I., DAVIS F.A. et coll. - New diagnostic criteria for multiple sclerosis : guidelines for research protocoles. Ann. Neurol., 1983, 13, 227-231.
3. MCDONALD W.I., COMPSTON A., EDAN G., GOODKIN D., HARTUNG H.P. et coll. Recommended diagnostic criteria for multiple sclerosis : guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol., 2001, 50, 121-127.
4. BEGAUD B., EVREUX J.C., JOUGLARD J., LAGIER G. - Unexpected or toxic drug reaction assessment (imputation). Actualisation of the method used in France. Thérapie, 1985, 40, 111-118.
5. OKSENBERG J.R., BARANZINI S.E., BARCELLOS L.F., HAUSER S.L. Multiple sclerosis : genomic rewards. J. Neuroimmunol., 2001, 113, 171-184.
6. ZHOU W., POOL V., ISKANDER J.K., ENGLISH-BULLARD R., BALL R. et coll. - Surveillance for safety after immunization. VAERS-United States, 1991-2001. In : Surveillance Summaries, 2003, MMWR 2003, 52/SS1, 1-24.